bloodthinner reversals

Octapharma secures FDA nod for warfarin reversal agent Balfaxar
Fierce Pharma
Wed, 07/26/23 - 06:43 pm
Octapharma
FDA
bloodthinner reversals
Balfaxar
PhaseBio Reversal Agent Continues to Show Promise in Phase III
BioSpace
Mon, 11/15/21 - 11:46 pm
PhaseBio
clinical trials
bentracimab
bloodthinner reversals
PhaseBio touts 'breakthrough' badge for bloodthinner reversal agent licensed from AstraZeneca, shares leap
Endpoints
Tue, 04/9/19 - 08:22 am
PhaseBio
Brilinta
PB2452
bloodthinner reversals
breakthrough status
AstraZeneca